• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of annrheumdAnnals of the Rheumatic DiseasesCurrent TOCInstructions for authors
Ann Rheum Dis. Jan 2005; 64(1): 13–20.
PMCID: PMC1755208

Low density of sympathetic nerve fibres and increased density of brain derived neurotrophic factor positive cells in RA synovium

Abstract

Objective: To investigate the correlation between density of nerve fibres and the presence of BDNF+ cells.

Methods: Densities of nerve fibres and BDNF+ cells were detected by quantitative immunohistochemistry in fresh synovial tissue from 52 patients with RA, 59 with OA, and 26 controls (Co). BDNF was also detected by in situ hybridisation.

Results: Sympathetic nerve fibre density was similar in Co and OA but markedly reduced in RA (p = 0.002), whereas density of substance P positive (SP+) sensory nerve fibres was lower in OA than in Co and RA (p = 0.002). The ratio of sympathetic/SP+ sensory nerve fibre density was highest in OA and Co, followed by RA. The correlation between density of sympathetic nerve fibres and SP+ sensory nerve fibres in OA (R = 0.425, p = 0.001) was strongly positive, had a positive trend in Co (R = 0.243, NS), but was negative in RA (R = –0.292, p = 0.040). In RA and OA tissue the density of BDNF+ cells was high in sublining areas but markedly lower in Co (p = 0.001). BDNF+ cell density correlated positively with the ratio of sympathetic/SP+ sensory nerve fibre density in Co (R = 0.433, p = 0.045) and in OA (R = 0.613, p = 0.015), but not in RA (R = 0.101, NS). Immunohistochemical double staining demonstrated that some macrophages and fibroblasts were positive for BDNF.

Conclusions: The correlation of density of SP+ sensory with sympathetic nerve fibres was positive in Co and OA but negative in RA. BDNF may have a stimulatory role on growth of sympathetic in relation to SP+ sensory nerve fibres in Co and OA, but not in RA.

Full Text

The Full Text of this article is available as a PDF (304K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Renz H, Gong JH, Schmidt A, Nain M, Gemsa D. Release of tumor necrosis factor-alpha from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J Immunol. 1988 Oct 1;141(7):2388–2393. [PubMed]
  • Le Moine O, Stordeur P, Schandené L, Marchant A, de Groote D, Goldman M, Devière J. Adenosine enhances IL-10 secretion by human monocytes. J Immunol. 1996 Jun 1;156(11):4408–4414. [PubMed]
  • Guirao X, Kumar A, Katz J, Smith M, Lin E, Keogh C, Calvano SE, Lowry SF. Catecholamines increase monocyte TNF receptors and inhibit TNF through beta 2-adrenoreceptor activation. Am J Physiol. 1997 Dec;273(6 Pt 1):E1203–E1208. [PubMed]
  • Straub Rainer H, Günzler Christian, Miller Luitpold E, Cutolo Maurizio, Schölmerich Jürgen, Schill Stefan. Anti-inflammatory cooperativity of corticosteroids and norepinephrine in rheumatoid arthritis synovial tissue in vivo and in vitro. FASEB J. 2002 Jul;16(9):993–1000. [PubMed]
  • Weiss M, Schneider EM, Liebert S, Mettler S, Lemoine H. Vasoactive drugs inhibit oxygen radical production of neutrophils. Immunopharmacol Immunotoxicol. 1997 May;19(2):239–263. [PubMed]
  • Kubersky SM, Hirschhorn R, Broekman MJ, Cronstein BN. Occupancy of adenosine receptors on human neutrophils inhibits respiratory burst stimulated by ingestion of complement-coated particles and occupancy of chemoattractant but not Fc receptors. Inflammation. 1989 Oct;13(5):591–599. [PubMed]
  • Fredholm BB, Zhang Y, van der Ploeg I. Adenosine A2A receptors mediate the inhibitory effect of adenosine on formyl-Met-Leu-Phe-stimulated respiratory burst in neutrophil leucocytes. Naunyn Schmiedebergs Arch Pharmacol. 1996 Aug-Sep;354(3):262–267. [PubMed]
  • Whalen MM, Bankhurst AD. Effects of beta-adrenergic receptor activation, cholera toxin and forskolin on human natural killer cell function. Biochem J. 1990 Dec 1;272(2):327–331. [PMC free article] [PubMed]
  • Schedlowski M, Falk A, Rohne A, Wagner TO, Jacobs R, Tewes U, Schmidt RE. Catecholamines induce alterations of distribution and activity of human natural killer (NK) cells. J Clin Immunol. 1993 Sep;13(5):344–351. [PubMed]
  • Nair MP, Schwartz SA, Wu K, Kronfol Z. Effect of neuropeptide Y on natural killer activity of normal human lymphocytes. Brain Behav Immun. 1993 Mar;7(1):70–78. [PubMed]
  • Priebe T, Kandil O, Nakic M, Pan BF, Nelson JA. Selective modulation of antibody response and natural killer cell activity by purine nucleoside analogues. Cancer Res. 1988 Sep 1;48(17):4799–4803. [PubMed]
  • Straub RH, Cutolo M. Involvement of the hypothalamic--pituitary--adrenal/gonadal axis and the peripheral nervous system in rheumatoid arthritis: viewpoint based on a systemic pathogenetic role. Arthritis Rheum. 2001 Mar;44(3):493–507. [PubMed]
  • Pereira da Silva JA, Carmo-Fonseca M. Peptide containing nerves in human synovium: immunohistochemical evidence for decreased innervation in rheumatoid arthritis. J Rheumatol. 1990 Dec;17(12):1592–1599. [PubMed]
  • Miller LE, Jüsten HP, Schölmerich J, Straub RH. The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages. FASEB J. 2000 Oct;14(13):2097–2107. [PubMed]
  • Miller Luitpold E, Grifka Joachim, Schölmerich Jürgen, Straub Rainer H. Norepinephrine from synovial tyrosine hydroxylase positive cells is a strong indicator of synovial inflammation in rheumatoid arthritis. J Rheumatol. 2002 Mar;29(3):427–435. [PubMed]
  • Konttinen YT, Kemppinen P, Segerberg M, Hukkanen M, Rees R, Santavirta S, Sorsa T, Pertovaara A, Polak JM. Peripheral and spinal neural mechanisms in arthritis, with particular reference to treatment of inflammation and pain. Arthritis Rheum. 1994 Jul;37(7):965–982. [PubMed]
  • Cerinic MM, Konttinen Y, Generini S, Cutolo M. Neuropeptides and steroid hormones in arthritis. Curr Opin Rheumatol. 1998 May;10(3):220–235. [PubMed]
  • Miller Luitpold E, Weidler Claudia, Falk Werner, Angele Peter, Schaumburger Jens, Schölmerich Jürgen, Straub Rainer H. Increased prevalence of semaphorin 3C, a repellent of sympathetic nerve fibers, in the synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum. 2004 Apr;50(4):1156–1163. [PubMed]
  • Kirstein M, Fariñas I. Sensing life: regulation of sensory neuron survival by neurotrophins. Cell Mol Life Sci. 2002 Nov;59(11):1787–1802. [PubMed]
  • Barbacid M. The Trk family of neurotrophin receptors. J Neurobiol. 1994 Nov;25(11):1386–1403. [PubMed]
  • Chalazonitis A. Neurotrophin-3 as an essential signal for the developing nervous system. Mol Neurobiol. 1996 Feb;12(1):39–53. [PubMed]
  • Shu XQ, Mendell LM. Neurotrophins and hyperalgesia. Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):7693–7696. [PMC free article] [PubMed]
  • Aloe L, Tuveri MA, Carcassi U, Levi-Montalcini R. Nerve growth factor in the synovial fluid of patients with chronic arthritis. Arthritis Rheum. 1992 Mar;35(3):351–355. [PubMed]
  • Braun A, Lommatzsch M, Lewin GR, Virchow JC, Renz H. Neurotrophins: a link between airway inflammation and airway smooth muscle contractility in asthma? Int Arch Allergy Immunol. 1999 Feb-Apr;118(2-4):163–165. [PubMed]
  • Cho HJ, Kim JK, Zhou XF, Rush RA. Increased brain-derived neurotrophic factor immunoreactivity in rat dorsal root ganglia and spinal cord following peripheral inflammation. Brain Res. 1997 Aug 1;764(1-2):269–272. [PubMed]
  • Kerschensteiner M, Gallmeier E, Behrens L, Leal VV, Misgeld T, Klinkert WE, Kolbeck R, Hoppe E, Oropeza-Wekerle RL, Bartke I, et al. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med. 1999 Mar 1;189(5):865–870. [PMC free article] [PubMed]
  • Barouch R, Appel E, Kazimirsky G, Braun A, Renz H, Brodie C. Differential regulation of neurotrophin expression by mitogens and neurotransmitters in mouse lymphocytes. J Neuroimmunol. 2000 Mar 1;103(2):112–121. [PubMed]
  • Toma Hiroki, Winston John H, Micci Maria-Adelaide, Li Hui, Hellmich Helen Lee, Pasricha Pankaj J. Characterization of the neurotrophic response to acute pancreatitis. Pancreas. 2002 Jul;25(1):31–38. [PubMed]
  • Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. [PubMed]
  • Harbuz MS, Lightman SL. Responses of hypothalamic and pituitary mRNA to physical and psychological stress in the rat. J Endocrinol. 1989 Sep;122(3):705–711. [PubMed]
  • Leibrock J, Lottspeich F, Hohn A, Hofer M, Hengerer B, Masiakowski P, Thoenen H, Barde YA. Molecular cloning and expression of brain-derived neurotrophic factor. Nature. 1989 Sep 14;341(6238):149–152. [PubMed]
  • Imai S, Tokunaga Y, Konttinen YT, Maeda T, Hukuda S, Santavirta S. Ultrastructure of the synovial sensory peptidergic fibers is distinctively altered in different phases of adjuvant induced arthritis in rats: ultramorphological characterization combined with morphometric and immunohistochemical study for substance P, calcitonin gene related peptide, and protein gene product 9.5. J Rheumatol. 1997 Nov;24(11):2177–2187. [PubMed]
  • Matucci-Cerinic M, Giacomelli R, Pignone A, Cagnoni ML, Generini S, Casale R, Cipriani P, Del Rosso A, Tirassa P, Konttinen YT, et al. Nerve growth factor and neuropeptides circulating levels in systemic sclerosis (scleroderma). Ann Rheum Dis. 2001 May;60(5):487–494. [PMC free article] [PubMed]
  • Dicou E, Perrot S, Menkes CJ, Masson C, Nerriere V. Nerve growth factor (NGF) autoantibodies and NGF in the synovial fluid: implications in spondylarthropathies. Autoimmunity. 1996;24(1):1–9. [PubMed]
  • Pezzati P, Stanisz AM, Marshall JS, Bienenstock J, Stead RH. Expression of nerve growth factor receptor immunoreactivity on follicular dendritic cells from human mucosa associated lymphoid tissues. Immunology. 1992 Jul;76(3):485–490. [PMC free article] [PubMed]
  • Morgan B, Thorpe LW, Marchetti D, Perez-Polo JR. Expression of nerve growth factor receptors by human peripheral blood mononuclear cells. J Neurosci Res. 1989 May;23(1):41–45. [PubMed]
  • Li AK, Koroly MJ, Schattenkerk ME, Malt RA, Young M. Nerve growth factor: acceleration of the rate of wound healing in mice. Proc Natl Acad Sci U S A. 1980 Jul;77(7):4379–4381. [PMC free article] [PubMed]
  • Lawman MJ, Boyle MD, Gee AP, Young M. Nerve growth factor accelerates the early cellular events associated with wound healing. Exp Mol Pathol. 1985 Oct;43(2):274–281. [PubMed]
  • Tuveri M, Generini S, Matucci-Cerinic M, Aloe L. NGF, a useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritis. Lancet. 2000 Nov 18;356(9243):1739–1740. [PubMed]
  • O'Connor BL, Brandt KD. Neurogenic factors in the etiopathogenesis of osteoarthritis. Rheum Dis Clin North Am. 1993 Aug;19(3):581–605. [PubMed]
  • O'Connor BL, Visco DM, Brandt KD, Myers SL, Kalasinski LA. Neurogenic acceleration of osteoarthrosis. The effects of previous neurectomy of the articular nerves on the development of osteoarthrosis after transection of the anterior cruciate ligament in dogs. J Bone Joint Surg Am. 1992 Mar;74(3):367–376. [PubMed]
  • Nilsson J, von Euler AM, Dalsgaard CJ. Stimulation of connective tissue cell growth by substance P and substance K. Nature. 1985 May 2;315(6014):61–63. [PubMed]
  • Ziche M, Morbidelli L, Pacini M, Dolara P, Maggi CA. NK1-receptors mediate the proliferative response of human fibroblasts to tachykinins. Br J Pharmacol. 1990 May;100(1):11–14. [PMC free article] [PubMed]
  • Katayama I, Nishioka K. Substance P augments fibrogenic cytokine-induced fibroblast proliferation: possible involvement of neuropeptide in tissue fibrosis. J Dermatol Sci. 1997 Sep;15(3):201–206. [PubMed]

Figures and Tables

Figure 1
 Representative immunohistochemistry of substance P (SP) positive sensory nerve fibres and sympathetic tyrosine hydroxylase (TH) positive nerve fibres. Note the typical juxtaposition of TH positive fibres and the structure of an artery (arrow ...
Figure 2
 Density of sympathetic and SP+ sensory nerve fibres in control subjects (Co), patients with OA, and RA. (A) Density of SP+ sensory nerve fibres; (B) density of sympathetic TH+ nerve fibres; and (C) ratio of density of sympathetic/SP+ sensory ...
Figure 3
 Interrelation between density of sympathetic TH+ nerve fibres and density of SP+ sensory nerve fibres in (A) control subjects (Co); (B) patients with OA; and (C) patients with RA. The linear regression line and its Pearson correlation coefficient ...
Figure 4
 Immunohistochemistry of BDNF in synovial tissue. (A) Synovial tissue from a control subject without an inflammatory condition (Co), a patient with OA, and a patient with RA stains positive for BDNF. APAAP staining was used. (B) BDNF in situ ...
Figure 5
 Density of BDNF+ cells in control subjects (Co), patients with OA, and patients with RA. Values of p for comparison of group medians are given.
Figure 6
 Interrelation of the density of BDNF+ cells and the ratio of the density of sympathetic TH+ nerve fibres/the density of SP+ sensory nerve fibres in (A) control subjects (Co); (B) patients with OA; and (C) patients with RA. The linear regression ...

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Group

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...